Press Releases Search News Category Company ReleasesCompany StatementsFinancial ReleasesProduct Releases Year None20222021202020192018201720162015201420132012201120102009200820072006 Date Title PDF Version Oct 23, 2019 Alexion Reports Third Quarter 2019 Results Oct 18, 2019 Alexion Receives FDA Approval for ULTOMIRIS® (ravulizumab-cwvz) for Atypical Hemolytic Uremic Syndrome (aHUS) Oct 16, 2019 Alexion to Acquire Achillion Oct 10, 2019 Alexion Announces Appointment of Tanisha Carino, Ph.D., as Chief Corporate Affairs Officer Oct 10, 2019 Alexion and Stealth Announce Agreement for Option to Co-Develop and Commercialize Late-Stage Therapy for Mitochondrial Diseases Oct 08, 2019 Alexion to Report Third Quarter 2019 Results On Wednesday, October 23, 2019 Sep 17, 2019 Alexion Announces CFO Succession Sep 09, 2019 Alexion and BridgeBio Announce Japanese License Agreement for Eidos’ Transthyretin Amyloidosis (ATTR) Investigational Medicine Sep 04, 2019 Alexion to Present at the 17th Annual Morgan Stanley Global Healthcare Conference Aug 28, 2019 Alexion Announces Upcoming Data Presentations at 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis Pagination First page « first Previous page ‹ previous … Page 4 Page 5 Page 6 Page 7 Current page 8 Page 9 Page 10 Page 11 Page 12 … Next page next › Last page last » Displaying 71 - 80 of 614